CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 93 filers reported holding CALITHERA BIOSCIENCES INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $117,000 | +77.3% | 22,158 | +31.9% | 0.02% | +63.6% |
| Q2 2019 | $66,000 | -66.2% | 16,803 | -45.5% | 0.01% | -62.1% |
| Q1 2018 | $195,000 | -64.5% | 30,830 | -11.5% | 0.03% | -67.4% |
| Q3 2017 | $549,000 | +57.3% | 34,845 | +48.4% | 0.09% | +34.8% |
| Q2 2017 | $349,000 | +86.6% | 23,477 | -59.2% | 0.07% | +32.0% |
| Q3 2016 | $187,000 | – | 57,565 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,072,000 | 4.00% |
| BVF INC/IL | 7,299,331 | $15,256,000 | 0.57% |
| TSP Capital Management Group, LLC | 463,500 | $969,000 | 0.32% |
| Tibra Equities Europe Ltd | 158,500 | $331,000 | 0.10% |
| Parkman Healthcare Partners LLC | 100,628 | $210,000 | 0.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,382 | $66,000 | 0.03% |
| FEDERATED HERMES, INC. | 6,668,978 | $13,938,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 108,111 | $226,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 133,580 | $279,000 | 0.02% |
| XTX Topco Ltd | 31,242 | $65,000 | 0.02% |